Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist
Listen now
Description
Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?
Credit available for this activity expires: 11/21/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer?
Credit available for this activity expires: 4/23/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000702?ecd=bdc_podcast_libsyn_mscpedu
Published 04/25/24
Published 04/25/24
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures:...
Published 04/25/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
